Not sure how close they are to finishing the oral formulation. I'm thinking the light bulbs got much brighter during the short trial and it may be pretty quick now.
We know they've been working on this for quite some time.


https://www.ipharminc.com/kevetrin-1/

https://static1.squarespace.com/static/571535...+FINAL.pdf

http://learningcenter.ehaweb.org/eha/2017/22n...acute.html

I'm not a scientist so won't pretend to know what I'm talking about. Following the biomarkers and gene / cell infiltration for an oral may be easier than I thought. Cancer cells literally anywhere in the body could be safely targeted, I'm just not quite sure how.